Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Vecuronium neuromuscular block in patients with malignant obstructive jaundice

References

  1. 1

    Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ. Clinical pharmacology of vecuronium and atracurium. Anesthesiology 1984; 61: 444–53.

  2. 2

    Lebrault C, Berger JL, D’Hollander AA, Gomeni R, Henzel D, Duvaldestin P. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) in patients with cirrhosis. Anesthesiology 1985; 62: 601–5.

  3. 3

    Lebrault C, Duvaldestin P, Henzel D, Chauvin M, Guesnon P. Pharmacokinetics and pharmacodynamics of vecuronium in patients with cholestasis. Br J Anaesth 1986; 58: 983–7.

  4. 4

    Bencini AF, Houwertjes MC, Agoston S. Effect of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking action in the cat. Br J Anaesth 1985; 57: 789–95.

  5. 5

    Bencini AF, Scaf AHJ, Sohn YJ, Kersten-Kleef UW, Agoston S. Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986; 58: 988–95.

  6. 6

    Upton RA, Nguyen T-L, Miller RD, Castagnoli N Jr. Renal and biliary elimination of vecuronium (ORG NC45) and pancuronium in rats. Anesth Analg 1982; 61: 313–6.

  7. 7

    Westra P, Keulemans GTP, Houwertjes MC, Hardonk MJ, Meijer DKF. Mechanisms underlying the prolonged duration of action of muscle relaxants caused by extrahepatic cholestasis. Br J Anaesth 1981; 53: 217–27.

Download references

Author information

Correspondence to Anis Baraka.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Baraka, A. Vecuronium neuromuscular block in patients with malignant obstructive jaundice. Can J Anaesth 41, 759–760 (1994). https://doi.org/10.1007/BF03015642

Download citation

Keywords

  • Vecuronium
  • Pancuronium
  • Atracurium
  • Neuromuscular Block
  • Hepatic Uptake